Type 2 Diabetes
The latest news about Type 2 Diabetes: headlines, AI summaries and the full story from every source.
- Eli Lilly's New Weight Loss Drug Shows Significant Results in Clinical Trial
- Eli Lilly Reports Improved Weight Loss with Combination Obesity Treatment in Mid-Stage Trial
- Ascendis Pharma Regains Rights to Metabolic Drug TransCon Semaglutide
- AstraZeneca Advances Oral GLP-1 Elecoglipron into Phase 3 Trials
- CrowdHealth Launches Program to Reverse Type 2 Diabetes
- Truist Reaffirms Buy Rating on Eli Lilly Following Positive Trial Results for Foundayo
- Eli Lilly's Obesity Pill Shows Cardiovascular Risk Reduction in Late-Stage Trial
- Eli Lilly Seeks FDA Approval for Foundayo in Type 2 Diabetes Patients